Skip to main content

Prelude Therapeutics Inc (PRLD) Stock

Prelude Therapeutics Inc Stock Details, Movements and Public Alerts

Stock Details

Prelude Therapeutics Inc (PRLD), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $1.66. Over the past 52 weeks, it has ranged between $0.61 and $4.22. This places the current price at 39.3% of its 52-week high and 172.1% above its 52-week low. Recent trading volume was recorded at 53,485. The 14-day Relative Strength Index (RSI) stands at 52.08, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $1.54 by 7.79%. Similarly, it is above its 200-day moving average of $1.06 by 56.60%. The MACD histogram is 0.01, indicating bullish momentum0. There are currently 3 active alerts set for PRLD by users.

52-Week Range

$4.22 - $0.61

-60.66% from high · +172.13% from low

Avg Daily Volume

430,285

20-day average

100-day avg: 897,846

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

1.80

EV/EBITDA

-0.54

EPS (TTM)

-$1.47

Price to Sales

10.06

Beta

1.06

Similar volatility to market

How is PRLD valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is PRLD's risk profile compared to the market?
With a beta of 1.06, Prelude Therapeutics Inc is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 1.80 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

-314.10%

EBITDA

$-119,267,000

Return on Equity

-104.00%

Return on Assets

-51.80%

Revenue Growth (YoY)

116.70%

Earnings Growth (YoY)

0.00%

How profitable and efficient is PRLD's business model?
0 The operating margin of -314.10% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -104.00% and ROA at -51.80%, the company achieves moderate returns on invested capital.
What are PRLD's recent growth trends?
Prelude Therapeutics Inc's revenue grew by 116.70% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends.0 These growth metrics should be evaluated against BIOTECHNOLOGY industry averages for proper context.

Company Size & Market

Market Cap

$105.6M

Revenue (TTM)

$10.50M

Revenue/Share (TTM)

$0.14

Shares Outstanding

50.02M

Book Value/Share

$0.77

Asset Type

Common Stock

What is PRLD's market capitalization and position?
Prelude Therapeutics Inc has a market capitalization of $105.6M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 50.02M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
How does PRLD's price compare to its book value?
Prelude Therapeutics Inc's book value per share is $0.77, while the current stock price is $1.66, resulting in a price-to-book (P/B) ratio of 2.16. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$4.00

140.96% upside potential

Analyst Recommendations

Strong Buy

1

Buy

2

Hold

0

Sell

0

Strong Sell

1

How reliable are analyst predictions for PRLD?
4 analysts cover PRLD with 75% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $4.00 implies 141.0% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on PRLD?
Current analyst recommendations:1 Strong Buy, 2 Buy, 001 Strong Sell. The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Dec 1, 2025, 02:03 AM

Technical Indicators

RSI (14-day)

52.08

Neutral

50-Day Moving Average

$1.54

7.79% above MA-50

200-Day Moving Average

$1.06

56.60% above MA-200

MACD Line

0.01

MACD Signal

N/A

MACD Histogram

0.01

Bullish

What does PRLD's RSI value tell investors?
The RSI (Relative Strength Index) for PRLD is currently 52.08, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
How should traders interpret PRLD's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.01 above the signal line at 0.00, with histogram at 0.01. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($1.54) is above the 200-day MA ($1.06), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Dec 12, 2025, 12:37 AM

Active Alerts

Alert Condition
Price decreases by
Threshold
7%
Created
Dec 10, 2025, 04:42 PM
Alert Condition
MA Breakout (Bearish)
Threshold
200 days
Created
Dec 9, 2025, 04:44 PM
Alert Condition
Price rises above
Threshold
$2.00
Created
Dec 5, 2025, 04:40 PM

Stay Ahead of the Market with Prelude Therapeutics Inc Alerts

Set up price alerts for Prelude Therapeutics Inc and get notified instantly when the price hits your target. Never miss an important price movement again.